Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella sativa in children with beta thalassemia major
NCT02816957Phase 1Unknown
- Sponsor
- Tanta University
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nigella sativa in beta thalassemia major, sponsored by Tanta University. Primary endpoints: malondialdehyde at 3 months and cluster of differentiation 4 and 8 at 3 months. Status: unknown.
02
Drugs
nigella sativa
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on NCT02816957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02816957.